| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $694.00K | $687.00K | $253.00K | $673.00K | $911.00K |
| SG&A | $366.00K | $271.00K | $562.00K | $660.00K | $1.64M |
| Operating Income | -$1.06M | -$958.00K | -$815.00K | -$1.33M | -$2.55M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$869.00K | -$680.00K | -$324.00K | -$1.81M | -$3.94M |
| EPS (basic) | -0.3200 | -0.1600 | -0.0800 | -0.3600 | -1.0000 |
| EPS (diluted) | -0.3200 | -0.1600 | -0.0800 | -0.3600 | -1.0000 |
| Shares (diluted) | $4.22M | $4.22M | $4.22M | $4.19M | $3.61M |